T&L Co. Ltd Asset Resilience Ratio
T&L Co. Ltd asset resilience ratio. T&L Co. Ltd (340570) has an Asset Resilience Ratio of 26.03% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 340570 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of T&L Co. Ltd (2017–2025)
Asset resilience ratio of T&L Co. Ltd from 2017 to 2025. This chart shows how T&L Co. Ltd's Asset Resilience Ratio has changed over time. Read T&L Co. Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down T&L Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see T&L Co. Ltd balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩65.91 Billion | 26.03% |
| Total Liquid Assets | ₩65.91 Billion | 26.03% |
Asset Resilience Insights
- Very High Liquidity: T&L Co. Ltd maintains exceptional liquid asset reserves at 26.03% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
T&L Co. Ltd Industry Peers by Asset Resilience Ratio
Compare T&L Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
T&L Co. Ltd Asset Resilience Ratio by Year (2017–2025)
T&L Co. Ltd asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for T&L Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 7.77% | ₩16.87 Billion ≈ $11.43 Million |
₩217.08 Billion ≈ $147.11 Million |
-30.34pp |
| 2024-12-31 | 38.11% | ₩75.10 Billion ≈ $50.89 Million |
₩197.08 Billion ≈ $133.56 Million |
+4.84pp |
| 2023-12-31 | 33.27% | ₩47.27 Billion ≈ $32.04 Million |
₩142.11 Billion ≈ $96.30 Million |
+6.23pp |
| 2022-12-31 | 27.04% | ₩31.64 Billion ≈ $21.44 Million |
₩117.00 Billion ≈ $79.29 Million |
-10.21pp |
| 2021-12-31 | 37.25% | ₩36.62 Billion ≈ $24.82 Million |
₩98.31 Billion ≈ $66.62 Million |
-6.33pp |
| 2020-12-31 | 43.59% | ₩34.63 Billion ≈ $23.47 Million |
₩79.45 Billion ≈ $53.84 Million |
+32.30pp |
| 2019-12-31 | 11.29% | ₩4.89 Billion ≈ $3.31 Million |
₩43.32 Billion ≈ $29.36 Million |
+3.73pp |
| 2018-12-31 | 7.56% | ₩2.76 Billion ≈ $1.87 Million |
₩36.53 Billion ≈ $24.76 Million |
+1.75pp |
| 2017-12-31 | 5.82% | ₩1.95 Billion ≈ $1.32 Million |
₩33.57 Billion ≈ $22.75 Million |
-- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more